CorVel (CRVL) Competitors

Laboratory Co. of America (NYSE:LH) and CorVel (NASDAQ:CRVL) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

Does the MarketBeat Community prefer LH or CRVL?

Laboratory Co. of America received 429 more outperform votes than CorVel when rated by MarketBeat users. Likewise, 63.99% of users gave Laboratory Co. of America an outperform vote while only 63.70% of users gave CorVel an outperform vote.

Company	Underperform	Outperform
Laboratory Co. of America	Outperform Votes 622 63.99%	Underperform Votes 350 36.01%
CorVel	Outperform Votes 193 63.70%	Underperform Votes 110 36.30%

Does the media refer more to LH or CRVL?

In the previous week, Laboratory Co. of America had 10 more articles in the media than CorVel. MarketBeat recorded 16 mentions for Laboratory Co. of America and 6 mentions for CorVel. Laboratory Co. of America's average media sentiment score of 1.19 beat CorVel's score of 0.63 indicating that Laboratory Co. of America is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Laboratory Co. of America	12 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of LH or CRVL?

95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 0.9% of Laboratory Co. of America shares are held by company insiders. Comparatively, 47.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Do analysts rate LH or CRVL?

Laboratory Co. of America currently has a consensus price target of $265.31, indicating a potential upside of 5.90%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, equities analysts clearly believe Laboratory Co. of America is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Laboratory Co. of America	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.88
CorVel	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has better valuation and earnings, LH or CRVL?

Laboratory Co. of America has higher revenue and earnings than CorVel. Laboratory Co. of America is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Laboratory Co. of America	$13.01B	1.61	$746M	$8.82	28.40
CorVel	$795.31M	7.03	$76.25M	$1.70	63.99

Which has more volatility & risk, LH or CRVL?

Laboratory Co. of America has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, CorVel has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.

Is LH or CRVL more profitable?

CorVel has a net margin of 10.12% compared to Laboratory Co. of America's net margin of 5.73%. CorVel's return on equity of 32.22% beat Laboratory Co. of America's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Laboratory Co. of America	5.73%	15.29%	7.01%
CorVel	10.12%	32.22%	17.66%

Summary

Laboratory Co. of America beats CorVel on 12 of the 19 factors compared between the two stocks.